Business Description
Susmed Inc
ISIN : JP3319150003
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 18.54 | |||||
Beneish M-Score | -2.41 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 143.4 | |||||
3-Year EBITDA Growth Rate | 36.8 | |||||
3-Year EPS without NRI Growth Rate | 21.5 | |||||
3-Year Book Growth Rate | 134.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.57 | |||||
9-Day RSI | 44.04 | |||||
14-Day RSI | 45.75 | |||||
6-1 Month Momentum % | -61.01 | |||||
12-1 Month Momentum % | -63.59 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 15.96 | |||||
Quick Ratio | 15.96 | |||||
Cash Ratio | 15.77 | |||||
Days Sales Outstanding | 14.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.3 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 96.37 | |||||
Operating Margin % | -107.05 | |||||
Net Margin % | -105.2 | |||||
FCF Margin % | 24.18 | |||||
ROE % | -7.42 | |||||
ROA % | -7.03 | |||||
ROIC % | -175.5 | |||||
ROCE % | -7.54 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 26.95 | |||||
PB Ratio | 1.95 | |||||
Price-to-Tangible-Book | 1.89 | |||||
Price-to-Free-Cash-Flow | 109.58 | |||||
Price-to-Operating-Cash-Flow | 89.76 | |||||
EV-to-EBIT | -11.64 | |||||
EV-to-EBITDA | -11.64 | |||||
EV-to-Revenue | 12.47 | |||||
EV-to-FCF | 54.99 | |||||
Price-to-Net-Current-Asset-Value | 1.9 | |||||
Price-to-Net-Cash | 1.93 | |||||
Earnings Yield (Greenblatt) % | -8.59 | |||||
FCF Yield % | 0.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Susmed Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 340.748 | ||
EPS (TTM) (円) | -21.655 | ||
Beta | 0 | ||
Volatility % | 65.18 | ||
14-Day RSI | 45.75 | ||
14-Day ATR (円) | 21.969705 | ||
20-Day SMA (円) | 546.45 | ||
12-1 Month Momentum % | -63.59 | ||
52-Week Range (円) | 504 - 1823 | ||
Shares Outstanding (Mil) | 16.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Susmed Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Susmed Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Susmed Inc Frequently Asked Questions
What is Susmed Inc(TSE:4263)'s stock price today?
When is next earnings date of Susmed Inc(TSE:4263)?
Does Susmed Inc(TSE:4263) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |